NO954381L - Nye aryloksymetyloksazoliner, fremgangsmåte ved deres fremstilling og farmasöytiske preparater inneholdende dem - Google Patents

Nye aryloksymetyloksazoliner, fremgangsmåte ved deres fremstilling og farmasöytiske preparater inneholdende dem

Info

Publication number
NO954381L
NO954381L NO954381A NO954381A NO954381L NO 954381 L NO954381 L NO 954381L NO 954381 A NO954381 A NO 954381A NO 954381 A NO954381 A NO 954381A NO 954381 L NO954381 L NO 954381L
Authority
NO
Norway
Prior art keywords
alkyl
new
aryloxymethyloxazolines
preparation
methods
Prior art date
Application number
NO954381A
Other languages
English (en)
Other versions
NO954381D0 (no
NO305755B1 (no
Inventor
Christian Jarry
Isabelle Forfar
Jean-Jacques Bosc
Pierre Renard
Elisabeth Scalbert
Beatrice Guardiola
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO954381D0 publication Critical patent/NO954381D0/no
Publication of NO954381L publication Critical patent/NO954381L/no
Publication of NO305755B1 publication Critical patent/NO305755B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO954381A 1994-11-03 1995-11-02 Nye aryloksymetyloksazoliner og farmas°ytiske preparater inneholdende dem NO305755B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9413087A FR2726558B1 (fr) 1994-11-03 1994-11-03 Nouvelles 5-(aryloxymethyl) oxazolines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO954381D0 NO954381D0 (no) 1995-11-02
NO954381L true NO954381L (no) 1996-05-06
NO305755B1 NO305755B1 (no) 1999-07-19

Family

ID=9468429

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954381A NO305755B1 (no) 1994-11-03 1995-11-02 Nye aryloksymetyloksazoliner og farmas°ytiske preparater inneholdende dem

Country Status (16)

Country Link
US (1) US5686477A (no)
EP (1) EP0710658B1 (no)
JP (1) JP3181211B2 (no)
CN (1) CN1051545C (no)
AT (1) ATE206414T1 (no)
AU (1) AU689320B2 (no)
CA (1) CA2162106C (no)
DE (1) DE69523011T2 (no)
DK (1) DK0710658T3 (no)
ES (1) ES2165410T3 (no)
FI (1) FI955238A7 (no)
FR (1) FR2726558B1 (no)
NO (1) NO305755B1 (no)
NZ (1) NZ280387A (no)
PT (1) PT710658E (no)
ZA (1) ZA959311B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635668B1 (en) * 1998-07-22 2003-10-21 The University Of North Carolina At Chapel Hill Imidazoline receptor binding compounds
US20020143090A1 (en) * 2001-01-16 2002-10-03 Pecorini Thomas Joseph Color concentrates for polyesters
US20040006092A1 (en) * 2001-08-31 2004-01-08 Neurochem, Inc. Amidine derivatives for treating amyloidosis
AU2003257418A1 (en) * 2002-06-19 2004-01-06 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
MX2009008465A (es) * 2007-02-15 2009-08-20 Hoffmann La Roche Nuevas 2-aminooxazolinas como ligandos de taar1.
CA2920856C (en) 2013-08-09 2026-03-03 Ardelyx, Inc. Ph modulating compounds for inhibiting gastrointestinal phosphate uptake
WO2016105449A1 (en) * 2014-12-22 2016-06-30 Seth Lederman Compounds for use as pain therapeutics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052688A (en) * 1962-09-04 Process for the production of
US3110650A (en) * 1961-09-14 1963-11-12 Szabo Hnos Kessler & Cia S R L Synergistic analgesic compositions
US3278382A (en) * 1962-07-23 1966-10-11 Mcneilab Inc 2-amino-5-aryloxazoline compositions and methods of using same
US3161650A (en) * 1963-01-25 1964-12-15 Mcneilab Inc 2-amino-5-aryloxazoline products
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
US3577428A (en) * 1969-04-14 1971-05-04 Colgate Palmolive Co 2-amino-4-aryloxyalkyl-4-alkyl-2-oxazolines
US3637726A (en) * 1970-04-09 1972-01-25 Dow Chemical Co Substituted-5-((3 4-dihalophenoxy)methyl)-2-oxazoline compounds
US3818028A (en) * 1972-11-01 1974-06-18 Dow Chemical Co Substituted-5-(2,4,6-trihalophenoxy)-methyl)-2-oxazoline compounds
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
FR2645860B1 (fr) * 1989-04-14 1991-07-26 Sarget Lab Nouvelles aryloxymethyl-5 amino-2 oxazolines, syntheses et applications therapeutiques

Also Published As

Publication number Publication date
ES2165410T3 (es) 2002-03-16
AU689320B2 (en) 1998-03-26
FI955238L (fi) 1996-05-04
JPH08208630A (ja) 1996-08-13
EP0710658B1 (fr) 2001-10-04
FR2726558B1 (fr) 1996-12-06
NO954381D0 (no) 1995-11-02
CN1129697A (zh) 1996-08-28
CA2162106C (fr) 2001-04-10
ZA959311B (en) 1996-05-29
EP0710658A1 (fr) 1996-05-08
NZ280387A (en) 1996-07-26
DE69523011D1 (de) 2001-11-08
DK0710658T3 (da) 2001-11-26
JP3181211B2 (ja) 2001-07-03
NO305755B1 (no) 1999-07-19
PT710658E (pt) 2002-02-28
US5686477A (en) 1997-11-11
CA2162106A1 (fr) 1996-05-04
CN1051545C (zh) 2000-04-19
FI955238A7 (fi) 1996-05-04
ATE206414T1 (de) 2001-10-15
FR2726558A1 (fr) 1996-05-10
AU3459395A (en) 1996-05-09
FI955238A0 (fi) 1995-11-01
DE69523011T2 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
GB9801690D0 (en) Therapeutic agents
NO20053460L (no) Nye forbindelser med selektiv inhibiterende effekt ved GSK3
DK0383579T3 (da) N-Phenyl-N-(4-piperidinyl)-amider, der er nyttige som analgetika
CA2284795A1 (en) Novel pyrimidine derivatives and processes for the preparation thereof
DK234388D0 (da) 1,4-dihydropyridin-forbindelser, farmaceutiske praeparater indeholdende disse og deres anvendelse til deres fremstilling af laegemidler samt beskyttede derivater deraf til anvendelse som udgangsmateriale ved deres fremstilling
DK0648771T3 (da) Galanthamin-derivat, en fremgangsmåde til dets fremstilling og dets anvendelse som medikament
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
NO954381D0 (no) Nye aryloksymetyloksazoliner, fremgangsmåte ved deres fremstilling og farmasöytiske preparater inneholdende dem
MXPA04009476A (es) Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7.
ATE129711T1 (de) Antipicornaviral-pyridazinamine.
NO933010D0 (no) 4-((2-benzotiazolyl)metylamino)alfa-((3,4-difluorfenoksy)metyl)-1-piperidinetanol
DK0902684T3 (da) Hexahydro-pyrido (4,3-B) indolderivater som antipsykotiske lægemidler
PE20040669A1 (es) Derivados de fenilalanina enamida
PE20050440A1 (es) Derivados de n-heterociclo sustituidos para modificar la recaptacion de monoaminas
AR044175A1 (es) Compuestos de cefemo
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
NO996284L (no) Nye imidazolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
TR200402720T4 (tr) Metalloproteaz inhibitörleri olarak 2-(4-piridinil)-benzofüran'lar
NO20030509D0 (no) Nye N-(2-fenyl-3-aminopropyl)naftamider
DK0475352T3 (da) 3-(1H-Indazol-3-yl)-4-pyridinaminer, fremgangsmåde og mellemprodukter til deres fremstilling og deres anvendelse som lægemidler
NO20002315D0 (no) Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
NO996285L (no) Nye spiroimidazolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
DK0531119T3 (da) N,N,N-trisubstituerede 5-bis-aminomethylen-1,3-dioxan-4,6-dioner som inhibitorer af acyl-CoA: cholesterol-acyltransferase
NO993608L (no) Nye 8H-tieno-[2,3-b]pyrrolizin-8-on forbindelser, fremgangsmåte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003